High @entity167 intake as a risk and prognostic factor for XXXX .

@entity1 @entity1143 @entity55 @entity167 @entity988 @entity794 @entity5132 @entity5882 @entity497 @entity358
OBJECTIVE: To evaluate whether high @entity167 intake is an independent risk factor for @entity497 in middle-aged @entity1 and whether it confers a poor prognosis. METHODS: A two-phase study was performed. Risk factors for @entity497 were evaluated in a case-control study of 50 @entity1 and 50 controls. Prognostic factors and microbiologic and clinical features were then evaluated in a cohort study of the 50 middle-aged @entity1 with @entity497 . RESULTS: In the first study, the only independent risk factor for @entity497 was high @entity167 intake (P < .02). In the second study, @entity1 with @entity5882 had a higher incidence of @entity55 caused by gram-negative bacilli (P < .03), as well as a higher incidence of @entity5132 (P < .03), @entity794 (P < .0001), and gram-negative bacilli (P < .001) in the cultures of pharyngeal smears than did the nonalcoholics. Compared with nonalcoholic @entity1 , @entity988 @entity1 with @entity55 showed more severe clinical symptoms (P < .02), required longer intravenous treatment (P < .02) and longer hospital stay (P < .01), and had multilobar involvement and @entity1143 (both P < .01), as well as slower resolution of @entity358 . The only prognostic factor for mortality was high @entity167 intake (P < .03). CONCLUSIONS: High @entity167 intake is the main risk factor for developing @entity497 in middle-aged @entity1 . This situation also confers a worse prognosis in these @entity1 , who should be treated with broad-spectrum antibiotics for a longer period.
